
1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
🕒 November 5
🌐 United States, United Kingdom – Remote
💵 $212k - $318k / year
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 10%
Where this job comes from
Posted on Jazz Pharmaceuticals's careers page ↗, not through a job board
First seen by Remote Rocketship November 5
Still open on Jazz Pharmaceuticals's site. Checked 3 hours ago.

1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
• Define and drive global and US payer evidence strategy for pipeline assets from Phase 2/3 through regulatory approval and launch • Lead global payer evidence generation while serving as the US HEOR lead • Develop US pre-launch HEOR deliverables, payer field enablement tools, and US market access evidence strategies • Translate target product profiles and access ambitions into evidence generation programs, including economic models, natural history studies, Global Value Dossiers, and US AMCP dossiers • Integrate global payer, US health plan, and HTA requirements into Phase 2 and pivotal Phase 3 study designs • Optimize trial protocols through comparator, inclusion/exclusion, treatment-line, and endpoint recommendations • Integrate PROs, HRQoL, symptom-burden scales, and HCRU instruments into pivotal trials • Design evidence strategies for rare-disease assets using natural history data, biomarkers, and external or historical comparators • Architect and lead health economic modeling strategies, including conceptual models, headroom/threshold analyses, CEAs, and BIMs • Direct the design, build, and validation of adaptable global core economic models • Lead US pre-launch evidence roadmaps, AMCP PIE dossiers, burden-of-illness dossiers, and US budget impact models • Design payer-facing economic models, evidence decks, and population health tools • Lead HEOR workstreams within cross-functional Launch Readiness Teams • Oversee GVDs, systematic literature reviews, value communication tools, ITCs, NMAs, and country model adaptations • Collaborate on pre-launch observational research, retrospective chart reviews, registries, and burden-of-illness evaluations • Govern the Integrated Evidence Generation Plan and coordinate evidence priorities, funding, and timelines • Develop scientific publication plans, manuscripts, and congress presentations • Mentor junior HEOR scientists, post-doctoral fellows, and matrix colleagues
• Master’s degree (MSc, MS, MPH, PhD) in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • Minimum of 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Deep technical and conceptual expertise in health economic modeling, including Markov state-transition, partitioned survival, microsimulation, and decision-tree models • Proven collaboration with Clinical Development, Commercial Development, and Biostatistics teams on Phase 2/3 trial design, comparator choice, resource-use collection, and PRO/HRQoL endpoint selection • Familiarity with US managed care and market access landscapes, including commercial payers, Medicare Advantage, Medicare Part D/B, Medicaid, and PBMs • Deep understanding of global HTA frameworks, including EU HTA Regulation/JCA, NICE, G-BA, PBAC, and CADTH • Demonstrated capability to lead HEOR launch-readiness workstreams and deliver GVDs, AMCP PIE dossiers, and global ITCs/NMAs • In-depth knowledge of rare disease/orphan drug evidentiary challenges, including natural history studies, registries, surrogate endpoints, external control arms, and specialized HTA pathways • Ability to define strategic vision while executing and quality-checking complex technical models, statistical analysis plans, and dossier sections • Demonstrated collaboration with regional HEOR teams, particularly EU/INT teams • Ability to influence cross-functional peers and senior leadership without formal authority • Exceptional written and verbal communication skills, with an established record of HEOR and clinical publications or HTA success • Experience leading HEOR strategy and deliverables for pipeline assets, including Phase 2/3 protocol integration, endpoint development, and global launch readiness • Experience managing regional trade-offs on evidence needs during Phase 2/3 protocol development • Launch lead for at least 2 assets as US HEOR lead or country-level HTA lead • Hands-on experience designing, overseeing, or adapting health economic models • Preferred experience with neurology assets • Preferred direct experience in rare disease, orphan drug, or highly specialized pipeline programs
• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants through the Long Term Equity Incentive Plan • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 November 5
Director leading Dermalogica’s U.S. partnership schools channel, P&L and field sales team. Growing esthetics-school revenue through partnerships, education, student programs and account development.
🕒 November 5
Interim Executive Director guiding CEJA, a California environmental justice alliance, through leadership transition. Overseeing programs, finances, fundraising, staff, governance, and member relationships.
🕒 November 4
WelbeHealth IT director leading enterprise technology portfolios, governance, and delivery. Aligning investments, budgets, and delivery practices to improve care for vulnerable seniors.
🇺🇸 United States – Remote
💵 $159.9k - $211.1k / year
💰 $30M Series C on 2020-02
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🕒 November 4
RCM director launching Practice by Numbers’ dental revenue cycle business. Building US and India teams, workflows, client services and revenue growth operations.
🕒 November 4
Director leading client partnerships and revenue cycle operations for Ensemble’s healthcare-system clients. Driving performance, reporting, compliance updates, and strategic service-line development.